Managing chronic pain or trauma after active duty can lead to substance dependence, making clinical withdrawal triage and tailored treatment vital.
If you are in immediate danger, call 911. For 24/7 support, call or text 988 and press 1 for the Veterans Crisis Line, or text 838255.
The clock on the nightstand shows 0315, and your sheets are soaked with sweat. Your heart thumps against your ribs as your mind replays memories from service, and your back aches from old injuries. You reach for the bottle on the dresser or the prescription bottle in the drawer, hoping four quick swallows will knock you out before your alarm sounds.
Substance use disorder is a treatable medical condition involving neurobiological adaptations, psychological stress, and physical health factors.
Seeking treatment for substance use is a clinical decision that can restore physical capability, mental clarity, and long-term health. Evidence-based care combines medical stabilization, pharmacotherapy, behavioral therapy, and integrated treatment for co-occurring conditions like post-traumatic stress disorder and chronic pain. Veterans can access confidential, structured care through the Department of Veterans Affairs, private medical networks, and community clinics regardless of their initial readiness for total abstinence.
Substance use disorder is a chronic, treatable medical condition characterized by clinically significant impairment, distress, and a loss of control over substance intake. It is not a failure of character, a lack of personal discipline, or a moral defect. The brain adapts to repeated exposure to alcohol, opioids, sedatives, or stimulants by altering neurotransmitter pathways that govern reward, stress regulation, and impulse control.
Clinicians evaluate substance use along a broad continuum rather than as an all-or-nothing label. The diagnostic spectrum includes:
Physical dependence can occur with properly prescribed pain medications or sleep aids and does not automatically equal an addiction disorder. However, when physical dependence combines with compulsive drug-seeking behaviors, cravings, and impaired daily functioning, a formal substance use disorder is present.
Military service places unique demands on the human body and mind. Understanding veteran substance use requires looking through a biopsychosocial lens that connects physical injury, psychological trauma, and social reintegration challenges.
Biologically, physical injuries sustained during active duty often lead to chronic musculoskeletal pain, joint degeneration, and traumatic brain injury. These physical challenges alter central nervous system signaling and elevate baseline stress hormones. Genetic factors and neurochemical adaptations further influence how an individual responds to alcohol, prescription analgesics, or stimulants.
Psychologically, exposure to combat, training accidents, military sexual trauma, and prolonged operational stress can create lasting hyperarousal, depression, and moral injury. Substances often become a coping mechanism to blunt emotional pain or suppress intrusive memories. This learned behavioral pattern reinforces psychological dependence over time.
Socially, the transition from military service to civilian life removes structured daily routines, close-knit unit camaraderie, and a clear chain of command. Social isolation, unemployment, relationship strain, and civilian misunderstandings can intensify distress. Addressing these interconnected factors is central to our work in veteran lifestyle and healthcare.
Research indicates that substance use concerns affect a notable portion of former service members. A national study established that past-year substance use disorder prevalence among veterans was 32.9% when including tobacco use and 17.1% when excluding it. Lifetime prevalence reached 52.5% with tobacco and 38.7% without it.
Among veterans entering Department of Veterans Affairs healthcare for the first time, approximately 11% meet the diagnostic criteria for a substance use disorder. Despite the availability of effective medical interventions, roughly 70% of veterans with a past-year disorder did not receive specialized care.
Interestingly, only 5.4% of those individuals reported an unmet need for treatment. This gap suggests that stigma, fear of career consequences, under-recognition of symptoms, and misconceptions about what treatment entails prevent many individuals from seeking assistance. A person does not need to hit rock bottom before engaging with professional care.
Different substances affect the central nervous system through distinct chemical mechanisms. Evaluating risk requires an understanding of how specific compounds alter physiology, cognition, and baseline health.
Alcohol remains the most commonly used substance among service members and veterans. Because alcohol is culturally normalized, risky consumption patterns often go unaddressed for years. In a 2025 study examining veterans receiving long-term opioid therapy, alcohol was the most common documented substance concern, affecting 9.8% of patients.
Heavy alcohol intake disrupts sleep architecture, suppresses restorative deep sleep, elevates resting heart rate, and raises systemic blood pressure. Chronic consumption impairs liver function, reduces endogenous testosterone production, worsens depressive symptoms, and damages gastrointestinal health. Abrupt cessation after prolonged, heavy use can produce severe, life-threatening withdrawal complications.
Opioid management requires distinguishing between prescribed pain therapies, diverted pharmaceuticals, illicit heroin, and synthetic compounds like fentanyl. Opioid analgesics bind to mu-opioid receptors in the central nervous system to reduce pain signals, but they also suppress respiratory drive and slow bowel motility.
Over time, the nervous system develops tolerance, requiring higher doses to achieve the same analgesic effect. This escalation can lead to physical dependence and opioid use disorder. Contamination of the illicit drug supply with illicitly manufactured fentanyl has dramatically increased fatal overdose rates. Even small amounts of synthetic opioids can cause rapid respiratory arrest, making access to rescue medications essential.
Stimulant use involves prescription compounds such as amphetamine salts or methylphenidate, as well as illicit substances like cocaine and methamphetamine. Stimulants increase dopamine and norepinephrine levels, producing temporary alertness, euphoria, and heightened energy.
Veterans experiencing extreme exhaustion, shift-work fatigue, or depression sometimes turn to stimulants to maintain daily performance. However, chronic stimulant use leads to cardiovascular strain, severe sleep deprivation, anxiety, paranoia, and stimulant-induced psychosis. When the drug wears off, the resulting neurological crash can trigger profound depressive episodes and elevated suicide risk.
Cannabis use among veterans has expanded alongside changing state laws and public perceptions. A nationally representative study found a past-six-month cannabis use rate of 11.9% and a cannabis use disorder rate of 2.7% among United States veterans.
Many veterans use cannabis to manage sleep disruption, chronic pain, or anxiety. While cannabis does not carry the same fatal overdose risks as opioids or sedatives, high-potency products can impair short-term memory, reaction time, and executive functioning. Heavy daily use can lead to tolerance, physical dependence, cannabis hyperemesis syndrome, and worsening anxiety or paranoia. Epidemiological studies have noted an association between cannabis use disorder and elevated suicidal ideation, highlighting the need for careful clinical monitoring.
Prescription central nervous system depressants include benzodiazepines such as alprazolam, clonazepam, lorazepam, and diazepam, along with non-benzodiazepine sleep aids. These medications enhance gamma-aminobutyric acid signaling to reduce anxiety and induce sedation.
While useful for short-term acute stabilization, long-term sedative use frequently causes tolerance, cognitive blunting, daytime lethargy, and physical dependence. When combined with alcohol or opioids, benzodiazepines multiply the risk of fatal respiratory depression. Abruptly stopping benzodiazepines after continuous use is medically dangerous and can trigger rebound panic, severe tremors, delirium, and life-threatening seizures.
Withdrawal occurs when the central nervous system experiences sudden removal of a substance to which it has adapted. The severity, duration, and medical danger of withdrawal vary significantly depending on the specific substance involved.
Alcohol and sedative withdrawal carry the highest risk of acute medical mortality. When chronic depressant exposure is stopped, the central nervous system experiences uncontrolled rebound excitation. Symptoms can progress rapidly from mild tremors, sweating, and nausea to hallucinations, autonomic instability, grand mal seizures, and delirium tremens.
Opioid withdrawal is intensely distressing but rarely life-threatening on its own in healthy adults. Symptoms include severe muscle aches, profuse sweating, rhinorrhea, nausea, severe abdominal cramping, vomiting, diarrhea, dilated pupils, and intense drug cravings. The primary medical danger of opioid withdrawal occurs later: if an individual loses tolerance during a period of abstinence and subsequently resumes their prior dose, their risk of fatal overdose surges.
Stimulant withdrawal does not typically cause life-threatening physical instability, but it creates profound neurochemical depletion. Individuals often experience severe fatigue, hypersomnia, vivid nightmares, ravenous hunger, psychomotor slowing, and severe anhedonia. Clinical monitoring during stimulant withdrawal must prioritize mental health, as severe depression and suicidal thoughts frequently emerge during this phase.
Cannabis withdrawal produces milder physiological disruption, usually peaking within the first week of cessation. Symptoms include irritability, anger, nervous tension, sleep disruption, strange dreams, decreased appetite, and restlessness. These symptoms can challenge a person's resolve to remain abstinent, but they do not require acute medical stabilization.
Healthcare professionals use standardized assessment tools to measure withdrawal severity and determine the appropriate level of medical intervention. For alcohol, clinicians frequently utilize the Clinical Institute Withdrawal Assessment for Alcohol. A score of 19 or higher indicates severe withdrawal that mandates pharmacotherapy and continuous medical monitoring.
Certain clinical presentations require immediate emergency intervention rather than routine outpatient scheduling. Emergency care must be sought immediately if a veteran experiences:
If an overdose is suspected, administer naloxone immediately and call 911. The Department of Veterans Affairs provides walk-in emergency evaluations at all VA medical centers. Veterans in crisis can also dial 988 and press 1 to connect directly with the Veterans Crisis Line, regardless of VA enrollment status.
Effective substance use treatment is not a one-size-fits-all program. Medical care follows a structured continuum that adjusts the intensity of clinical support to match the individual's physiological stability, psychiatric needs, and recovery goals.
The treatment pathway begins with a comprehensive, collaborative evaluation. A clinical provider assesses substance consumption history, prior withdrawal episodes, medical history, pain conditions, sleep patterns, psychiatric symptoms, and social stability. Toxicology testing may be used to establish baseline exposures, but laboratory results alone do not define the presence or severity of an addiction disorder.
When physical dependence creates a risk of complicated withdrawal, medical detoxification serves as the entry point. Detoxification involves the safe, medically supervised clearance of substances from the body. Medications such as benzodiazepines for alcohol withdrawal or buprenorphine for opioid withdrawal are administered on a tapering schedule to prevent complications and relieve distress.
Detoxification alone is not comprehensive treatment. National Institute on Drug Abuse guidelines clarify that medical stabilization without subsequent therapy and ongoing care results in high rates of immediate relapse. Detoxification prepares the nervous system for the actual work of long-term behavioral and medical rehabilitation.
Following stabilization, patients transition into a structured level of care based on their clinical needs:
Level-of-care decisions depend on personal safety, home environment stability, psychiatric stability, and functional capability. A veteran can move fluidly between these levels as their health improves or when life stressors escalate.
Harm reduction focuses on minimizing the adverse health, social, and legal consequences of substance use. It does not require immediate abstinence to engage with supportive care. Harm reduction recognizes that keeping a person alive and medically stable is the necessary foundation for future recovery.
Evidence-based harm reduction interventions include:
The Department of Veterans Affairs actively integrates harm reduction into clinical care by providing free naloxone to veterans at risk of opioid overdose and educating patients on overdose prevention.
Pharmacotherapy is an established medical intervention for substance use disorders. Medications normalize brain chemistry, block the euphoric effects of substances, relieve physiological cravings, and reduce the risk of fatal overdose.
The scientific evidence supporting medication for opioid use disorder is extensive. The three primary medications utilized in clinical practice include:
VA clinical guidelines recommend maintaining opioid use disorder medications for at least one year, and many individuals benefit from long-term, indefinite maintenance. The American Society of Addiction Medicine states that medications should not be withheld or discontinued simply because a patient continues to use cannabis, stimulants, or alcohol.
Multiple medications are approved and clinically established to support recovery from alcohol use disorder:
Medication selection depends on individual organ function, co-occurring pain treatment needs, kidney health, and patient preferences. Liver enzymes must be evaluated when initiating naltrexone, while kidney function determines acamprosate dosing.
For tobacco and nicotine dependence, evidence-based pharmacotherapies include nicotine replacement therapy (patches, gum, lozenges), bupropion, and varenicline. These medications double or triple long-term smoking cessation rates compared to unassisted quit attempts.
Currently, there are no FDA-approved medications specifically indicated for the treatment of stimulant use disorder or cannabis use disorder. Medical care for these conditions focuses on behavioral therapies, psychiatric management of co-occurring symptoms, sleep stabilization, and supportive medical monitoring. Research into novel pharmacotherapies, including glutamate modulators and immunotherapies, remains in early clinical phases.
Substance use among veterans rarely occurs in isolation. It frequently intersects with post-traumatic stress disorder, persistent musculoskeletal pain, traumatic brain injury, and chronic insomnia.
VA National Center for PTSD data shows that approximately 45% of adults with lifetime PTSD also meet criteria for a substance use disorder. Veterans with lifetime PTSD are twice as likely to develop alcohol use disorders and three times as likely to develop drug use disorders compared to peers without trauma histories.
Among Iraq and Afghanistan veterans diagnosed with lifetime PTSD, research indicates that 34.2% of men and 20.1% of women experience an alcohol use disorder. Corresponding drug use disorder rates are 17.3% for men and 10.5% for women.
Historical treatment models required a veteran to achieve months of complete sobriety before initiating trauma-focused psychological care. Modern clinical guidelines reject this sequential approach. Delaying trauma therapy often leads to relapse, as the untreated PTSD symptoms drive continued substance use. Integrated therapies, which address trauma processing and addiction coping skills concurrently, produce superior long-term clinical outcomes.
Several evidence-based psychotherapies demonstrate strong efficacy for veterans navigating co-occurring conditions:
These modalities can be pursued alongside peer-led support groups, mutual-help fellowships, and family counseling to build a comprehensive recovery environment.
Chronic pain and sleep disruption are powerful drivers of substance use relapse. When pain flares or insomnia persists, individuals naturally seek rapid relief.
Managing pain requires a multimodal strategy that minimizes dependence on high-dose opioids. Non-opioid pharmacotherapy, physical therapy, targeted mobility training, and interventional procedures help restore functional movement. Managing systemic inflammation through structured physical activity and restorative sleep reduces baseline pain sensitivity.
Sleep architecture must be actively rebuilt. While alcohol and sedatives induce rapid drowsiness, they fragment slow-wave sleep and suppress rapid eye movement sleep. Cognitive Behavioral Therapy for Insomnia is the gold-standard first-line treatment for chronic insomnia in veterans. Addressing sleep apnea, establishing consistent sleep schedules, and optimizing bedroom environments are critical steps detailed in our guides on recovery and sleep.
Examining real-world clinical patterns illustrates how substance use concerns manifest in daily veteran life and how structured medical interventions provide practical solutions.
A 34-year-old combat veteran drinks six to eight high-gravity beers every evening to suppress intrusive thoughts and fall asleep. Over two years, morning tremors and daytime irritability develop, requiring an earlier drink to feel steady.
The clinical approach involves a comprehensive evaluation of alcohol consumption, morning withdrawal symptoms, liver enzymes, and PTSD severity. Because of the tremor history, an outpatient medical taper using a brief course of benzodiazepines is administered to ensure safe withdrawal. The veteran starts naltrexone to reduce evening cravings, begins Cognitive Processing Therapy for PTSD, and engages with an evidence-based sleep protocol. Within three months, sleep quality improves and alcohol cravings drop significantly.
A 48-year-old veteran with service-connected spinal injuries takes prescribed oxycodone for a decade. Over time, the medication provides less pain relief, leading the veteran to take extra doses and seek additional prescriptions from non-VA urgent care clinics.
The care team distinguishes between tolerance, physical dependence, and opioid use disorder. Instead of an abrupt, unmonitored taper, the provider transitions the veteran to buprenorphine-naloxone. This transition relieves withdrawal, stabilizes mu-opioid signaling, and provides sustained baseline analgesia without cognitive clouding. The patient is co-prescribed naloxone for emergency safety and enrolled in a functional physical rehabilitation program.
A 29-year-old veteran working long industrial shifts experiences severe fatigue driven by untreated hyperarousal and nightmares. To maintain daytime performance, the veteran begins using illicit methamphetamine several mornings per week.
The clinical evaluation prioritizes cardiovascular screening, psychiatric assessment for stimulant-induced paranoia, and suicide risk evaluation during the withdrawal crash. Because no FDA-approved medications exist for stimulant use disorder, the veteran enrolls in a VA Contingency Management program paired with Cognitive Behavioral Therapy. The clinician coordinates with a mental health provider to treat the underlying hyperarousal, allowing normal sleep cycles to return.
A 55-year-old veteran has taken prescribed clonazepam daily for seven years to manage service-connected panic disorder. The veteran wants to stop the medication immediately after reading about long-term cognitive risks.
The clinician strongly advises against abrupt discontinuation, explaining the severe risks of withdrawal seizures and rebound anxiety. The provider designs a gradual, supervised taper lasting six to nine months, reducing the daily dose by small increments every few weeks. Concurrently, the veteran learns non-pharmacological anxiety regulation techniques and somatic grounding strategies, successfully eliminating the medication without medical complications.
A 41-year-old veteran consumes high-potency cannabis concentrates throughout the day to suppress service-related anxiety and chronic joint discomfort. Over time, the veteran notes worsening daytime apathy, short-term memory lapses, and severe morning anxiety when cannabis is delayed.
The clinician conducts an objective, non-judgmental review of how cannabis impacts daily functioning, motivation, and mood. The veteran agrees to a structured reduction plan, utilizing behavioral coping strategies, aerobic exercise, and non-narcotic pain therapies. As cannabis use decreases, the veteran's daytime cognitive clarity returns, and baseline anxiety stabilizes through structured behavioral therapy.
A 38-year-old veteran takes prescribed alprazolam for panic attacks, takes hydrocodone for an old knee injury, and drinks bourbon on weekends. The veteran experiences frequent memory blackouts and daytime respiratory grogginess.
This pattern represents a severe overdose risk due to synergistic central nervous system depression. The medical team initiates an urgent safety intervention. The veteran and their spouse receive naloxone training and rescue kits. The care team develops a coordinated, step-wise deprescribing plan to eliminate the dangerous sedative-opioid-alcohol combination, replacing it with targeted physical therapy and non-sedating psychiatric care.
Navigating substance use recovery is often hindered by widespread misconceptions that delay effective medical care.
A persistent cultural myth suggests that an individual must lose their job, family, or freedom before treatment can work. In reality, earlier clinical intervention preserves neurological health, prevents organ damage, and protects personal relationships. Treatment can begin when a person simply wants to reduce intake, improve physical health, or regain control over daily habits.
Completing a five-day medical detox program does not cure a substance use disorder. Detoxification only stabilizes acute physical withdrawal. Without continuing outpatient therapy, medication maintenance, and relapse prevention planning, the neurological and behavioral drivers of addiction remain active, leading to high rates of immediate relapse.
Viewing medications for opioid or alcohol use disorder as replacing one addiction with another is medically incorrect. Addictive substance use involves compulsive behavior, loss of control, cognitive impairment, and continuous harm. Evidence-based pharmacotherapies like buprenorphine, methadone, or naltrexone stabilize neurochemistry, eliminate cravings, prevent withdrawal, and restore normal daily functioning without producing intoxication.
Attempting to quit heavy alcohol or long-term benzodiazepine use through sheer willpower without medical oversight can be fatal. Rebound central nervous system excitation can cause uncontrollable seizures and autonomic collapse within 24 to 72 hours of cessation. Supervised medical stabilization is a necessary safety protocol.
Many veterans incorrectly believe that an other-than-honorable discharge or lack of active VA healthcare enrollment prevents them from accessing emergency mental health and substance care. Federal policy guarantees that any veteran experiencing an acute mental health or substance crisis can receive emergency assessment and stabilization at any VA or civilian emergency department at no cost.
Long-term recovery is an active process of maintaining physical health, emotional resilience, and functional capability over months and years. It requires intentional planning, lifestyle structure, and ongoing support.
A practical relapse prevention plan serves as an operational strategy for managing high-risk situations. A comprehensive plan should document:
Relapse should not be viewed as a total moral failure or proof that recovery is impossible. A recurrence of symptoms is a clinical signal that the current management plan requires adjustment, such as modifying medication dosing, increasing therapy frequency, or addressing an emerging life stressor.
Recovery capital refers to the internal and external resources an individual can draw upon to initiate and sustain long-term health. These resources include:
Developing healthy daily routines reinforces recovery. Engaging in regular resistance training, outdoor activities, and cardiovascular conditioning restores dopaminergic tone and reduces anxiety. Learning how to manage stress through evidence-based practices is explored further in our materials on sleep, stress, and resilience.
Relapse vulnerability spikes during major life transitions. Critical periods that demand proactive planning include:
Proactively scheduling support contacts and maintaining open communication with healthcare providers ensures that stability is preserved through every life stage. For more information on navigating civilian life and health systems, visit our broader library of veteran health resources and explore related military health topics.
This article is for educational and informational purposes only and does not constitute formal medical advice, clinical diagnosis, or personalized treatment recommendations. Substance use disorders and medical withdrawal syndromes can involve complex, life-threatening complications. Always consult with a qualified physician, addiction medicine specialist, or licensed mental health provider before starting, stopping, or modifying any medication, taper protocol, or treatment plan. If you or someone you know is experiencing a life-threatening medical emergency or severe overdose, call 911 immediately.
No. Seeking medical or psychiatric treatment for a substance use disorder will not cause you to lose your service-connected disability compensation. The Department of Veterans Affairs encourages veterans to seek healthcare, and medical records regarding substance use treatment are protected under strict federal privacy regulations (including 38 U.S.C. 7332 and HIPAA). Disclosing substance use to your clinical team allows for safer prescribing and more effective care.
Physical dependence is a normal physiological adaptation that occurs when the body becomes accustomed to the presence of a substance, resulting in tolerance and withdrawal if stopped. Dependence frequently happens with properly managed, prescribed blood pressure medications, antidepressants, and pain therapies. Addiction (substance use disorder) involves compulsive drug seeking, loss of control over consumption, persistent cravings, and continued use despite severe negative consequences to health, employment, or personal relationships.
Clinical practice guidelines recommend maintaining medication treatment, such as buprenorphine or methadone, for at least one year. However, treatment duration is highly individualized. Many individuals benefit from staying on maintenance medications for several years or indefinitely. Long-term maintenance significantly lowers mortality rates, prevents fatal overdoses, and supports sustained personal and occupational stability. Any decision to reduce or discontinue medication should be made collaboratively with your prescribing clinician.
Mutual-help peer groups provide valuable community, accountability, and practical coping strategies. However, peer groups are not medical or psychological treatments. For many individuals, especially those with moderate-to-severe substance use disorders, physical dependence, or co-occurring PTSD and depression, peer support works best as an adjunct to professional medical care, evidence-based psychotherapy, and prescribed pharmacotherapy.
Revisit this guide if your daily substance use patterns begin to change, if you find yourself relying on substances to manage worsening pain or sleep disruption, or if a planned life transition creates heightened stress. Review these protocols if you are supporting a fellow veteran who is showing signs of withdrawal, escalating substance intake, or social isolation.
Taking control of your recovery is an ongoing, proactive health decision that preserves your long-term capability, independence, and overall quality of life.
Follow BattleVet for practical guidance on military and veteran health, strength, recovery, testosterone, sleep and healthy aging. Stay connected for new articles, research backed insights and clear information to help you stay capable for the years ahead.
Build better habits around strength, recovery, sleep, hormones and healthy aging with practical guidance for active military personnel and veterans.
Explore BattleVet
